🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I'm very much looking forward to some thoughtful discussion...and need to get cracking on making my slides!

Our study published today suggests that cascade genetic testing of siblings would reduce cancer deaths by over 50%. Still much work needs to be done in this area.

Now in press: bit.ly/3B8vR7r Nice job, Julia Wynn and Hila Milo Rasouly. Interesting to re-read, "The most common reasons indicated for not sharing were that the family members were too young (38%)" just after our cascade testing paper was published bit.ly/3aSzuDz

#ImpSci in action as we bring PGx testing to Vets

Check it out! cell.com/ajhg/fulltext/…

For you job seekers, Stacey has a rare combination of qualitative and quantitative expertise. She's a wonderful colleague, too!

Now in press: awareness about, use of, & perceived utility of genetic testing among over 5,500 Hispanic Community Health Study / Study of Latinos participants cell.com/hgg-advances/f…. Thank you to HCHS/SOL investigators and participants! sites.cscc.unc.edu/hchs/ #genetictesting

Very happy to share this research that explores how caregivers of pediatric patients with suspected genetic conditions approach decision-making about genomic sequencing, with a specific focus on family-level considerations. Read the full article here: rdcu.be/c0qcU

How frequently do relatives of patients with positive #exome sequencing results complete cascade testing? Using data from two US labs, we found that fewer than 8% of probands had at least one relative tested. Terrific work led by Julie BCM Genetic Counseling Program authors.elsevier.com/c/1gsqQ3vlFV0S…

Is genetic screening for "CDC Tier 1" conditions cost effective? Read for yourself at acpjournals.org/doi/10.7326/M2…. Rigorous work from a good group.

Our comparison of the medical impact of preemptive and reactive PGx testing to inform antiplatelet therapy is now in press at European Journal of Human Genetics! nature.com/articles/s4143… Sanford Health PROMoTeR_DPM

With Hadley Stevens Smith at her #PreEMPT Model poster ACMG Annual meeting. Catch Hadley at poster P858 10:30-12:00 Friday about provider and patient attitudes toward genome sequencing #babyseq PROMoTeR_DPM

I am hiring a postdoc to work on health econ topics related to Neurofibromatosis type 1 (NF1), a genetic tumor predisposition syndrome. 🧬 Work with a collaborative team of outcomes researchers and clinicians at CHeRP & Harvard hospitals. Apply here: tuftshealthplan.wd5.myworkdayjobs.com/THP/job/Boston…

Hello academia. Isdin Oke, is hiring a research assistant. Dr. Oke’s research is in the area of ophthalmology with a strong focus on disparities and access to care. Candidates should experience with R and health services research methods. Learn more at shorturl.at/qsDEV.

🌟 Exciting News! 🌟We are thrilled to congratulate our colleague, Sophia Adelson, on successfully leading the publication of her first, first-author manuscript, "Familial Communication and Cascade Testing Following Elective Genomic Testing"! Read Here: genomes2people.org/wp-content/upl…

Huge congratulations to Sophia Adelson for leading these analyses about familial communication and cascade testing data following genetic testing offered as an elective clinical service at Sanford Health.

"Evaluating the utility of multi-gene, multidisease population-based panel testing accounting for uncertainty in penetrance estimates", now in press at #NPJgenomicMedicine at rdcu.be/dItqx. Kudos to Jane Liang for leading this important work (complete with RShiny app!)

Haven't had a chance thank my co-authors for this important paper, led by Dr. Deborah A Marshall Research Team, from the GEECS group!

Big step. Medicare hadn't been able to negotiate drug prices despite the vast needs of seniors. The US wildly outspends most countries on health (and gets less. shorturl.at/l4cQv). As others' have stated more elegantly, "it's the prices, ___" (shorturl.at/jq7NO)

Now in press: acceptance of recommendations from PGx clinical decision support for clopidogrel increased from 24% in 2015 to 63% in 2023. Wow. Great work by #pharmacogenomics at Sanford Health! tandfonline.com/doi/full/10.10…